Q: Clearly yesterday's announcement of the commercialization of their smarTR(TM) along with landing a significant contract was exceptionally well received by the market. As always, would appreciate your analysis.
5i Research Answer:
It was a big move, and the stock is now up nearly 30% in three days. Commercialization of course reduces risk (everything works) and the $11M contract represents more than 10% of annual revenue. For a small cap company in an uncertain market, it gives investors a lot more confidence in the short, and probably long, term. The stock remains cheap at just under 10X earnings.